2025 年年度报告 【2026 年 3 月】 1 浙江大立科技股份有限公司 2025 年年度报告全文 浙江大立科技股份有限公司 公司负责人庞惠民、主管会计工作负责人徐之建及会计机构负责人（会 计主管人员）莫圆成声明：保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中所涉及的未来计划、发展战略等前瞻性描述，不代表公司盈利 预测，不构成公司对投资者的实质承诺，投资者及相关人士均应对此保持足 够的风险认识，并且应当理解计划、预测与承诺之间的差异。请投资者注意 投资风险。 公司在本报告第三节"管理层讨论与分析"之"十一、公司未来发展的 展望"中描述了公司未来经营中可能面临的风险以及 2026 年度经营计划，敬 请广大投资者注意阅读。 根据《深圳证券交易所股票上市规则》第 9.3.8 条规定，公司已符合申 请撤销退市风险警示的条件，并于 2026 年 3 月 26 日向深圳证券交易所提交 了撤销退市风险警示的申请。该申请尚需深圳证券交易所核准，能否获得批 准存在不确定性。敬请广大投资者理性投资，注意投资风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 浙江 ...

浙江大立科技股份有限公司 证券代码：002214 证券简称：*ST 大立 公告编号：2026－019 关于 2025 年度拟不进行利润分配的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或者重大遗漏。 根据《深圳证券交易所股票上市规则》第 5.3.2 条"上市公司利润分配应当 以最近一期经审计母公司报表中可供分配利润为依据，合理考虑当期利润情况， 并按照合并报表、母公司报表中可供分配利润孰低的原则确定具体的利润分配比 例，避免出现超分配的情况"的规定情形，鉴于公司报告期末合并报表和母公司 报表可供分配利润均为负值，为保障公司正常生产经营和未来发展，公司决定 2025 年度利润分配预案为：不派发现金股利，不送红股，不以公积金转增股本。 本议案需提交公司 2025 年度股东会审议。 结合上述指标，公司未触及《深圳证券交易所股票上市规则》第9.8.1 条规 定的可能被实施其他风险警示的情形。 四、公司2025年度不进行利润分配的合理性说明 浙江大立科技股份有限公司（以下简称"公司"）于2026年3月25日召开的 第七届董事会第十六次会议，审议通过了《浙江大立科技股份有限公 ...

证券代码：002214 证券简称：*ST 大立 公告编号：2026－016 浙江大立科技股份有限公司关于公司股票 可能被终止上市的第四次风险提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或者重大遗漏。 特别提示： 1、浙江大立科技股份有限公司（以下简称"公司"）已于 2025 年 1 月 27 日披露了《关于公司股票交易可能被实施退市风险警示的提示性公告》（公告编 号：2025-010），公司股票于 2025 年 4 月 29 日开市起被实施退市风险警示。若 公司 2025 年度出现《深圳证券交易所股票上市规则》（以下简称"《股票上市规 则》"）第 9.3.12 条规定情形之一，公司股票将存在被终止上市的风险。 2、根据《股票上市规则》第 9.3.6 条规定："上市公司因触及本规则第 9.3.1 条第一款第一项至第三项情形，其股票交易被实施退市风险警示后，应当在其股 票交易被实施退市风险警示当年会计年度结束后一个月内，披露股票可能被终止 上市的风险提示公告，在首次风险提示公告披露后至年度报告披露前，每十个交 易日披露一次风险提示公告。"公司应当披露股票可能被终止 ...

Core Insights - The report identifies a new cycle in China's defense equipment construction driven by "steady growth in traditional military industry" and "rapid development of civilian conversion of military technology" [4] - Traditional military industry is expected to continue its systematic and long-term progress, supported by key milestones such as the centenary of the People's Liberation Army in 2027 and the modernization goals by 2035 [4] - The civilian conversion of military technology is accelerating, creating new growth opportunities in various emerging industries, significantly enhancing the industry's elasticity [4] Group 1: Domestic and International Market Dynamics - The domestic market is expected to stabilize, while the international market presents new expansion opportunities for military trade [5][17] - The "14th Five-Year Plan" is initiating a new construction cycle, with a focus on enhancing military capabilities through mechanization and information technology [7][19] - The military trade landscape is evolving, with a shift towards a more integrated and systematic approach to military exports [52][56] Group 2: Military Technology Spillover - Military technology is increasingly spilling over into civilian applications, broadening the growth space and enhancing elasticity in the military industry [70][73] - Key areas of focus include commercial aerospace, advanced aircraft engines, controllable nuclear fusion, and deep-sea technology, which are expected to drive long-term growth [4][80] - The report emphasizes the importance of technological breakthroughs and cost reductions in facilitating the transition from military to civilian applications [76] Group 3: Investment Opportunities - The report highlights specific sectors for investment, including commercial aerospace, the dual-use aircraft industry, and controllable nuclear fusion [4][19] - The commercial aerospace sector is positioned for rapid growth, supported by national policies that prioritize aerospace as a key emerging industry [80][82] - The dual-use aircraft industry is expected to benefit from a resonance of military and commercial development, enhancing overall market potential [4][19]

一、2025 年年度报告编制及最新审计进展情况 1.公司 2025 年年度报告的预约披露日期为 2026 年 3 月 27 日，截至本公告 披露日，公司 2025 年年审工作仍在进行中，最终财务数据以公司正式披露的经 审计后的 2025 年年度报告为准。 1、浙江大立科技股份有限公司（以下简称"公司"）已于 2025 年 1 月 27 日披露了《关于公司股票交易可能被实施退市风险警示的提示性公告》（公告编 号：2025-010），公司股票于 2025 年 4 月 29 日开市起被实施退市风险警示。若 公司 2025 年度出现《深圳证券交易所股票上市规则》（以下简称"《股票上市规 则》"）第 9.3.12 条规定情形之一，公司股票将存在被终止上市的风险。 2、根据《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监 管指南第 1 号——业务办理》的有关规定，财务类退市风险公司应当分别在年度 报告预约披露日前二十个交易日和十个交易日，披露年度报告编制及最新审计进 展情况。 为方便投资者能够及时了解公司年度报告的编制及审计进度，公司现将 2025 年年度报告编制及最新审计进展情况公告如下： 证券代码：002 ...

浙江大立科技股份有限公司关于公司股票 可能被终止上市的第三次风险提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或者重大遗漏。 特别提示： 1、浙江大立科技股份有限公司（以下简称"公司"）已于 2025 年 1 月 27 日披露了《关于公司股票交易可能被实施退市风险警示的提示性公告》（公告编 号：2025-010），公司股票于 2025 年 4 月 29 日开市起被实施退市风险警示。若 公司 2025 年度出现《深圳证券交易所股票上市规则》（以下简称"《股票上市规 则》"）第 9.3.12 条规定情形之一，公司股票将存在被终止上市的风险。 证券代码：002214 证券简称：*ST 大立 公告编号：2026－014 公司于 2025 年 4 月 26 日在指定信息披露媒体上披露了《关于公司股票交易 被实施退市风险警示暨停牌的公告》（公告编号：2025-026），公司 2024 年度经 审计的财务数据触及《股票上市规则》第 9.3.1 条"（一）最近一个会计年度经 审计的利润总额、净利润、扣除非经常性损益后的净利润三者孰低为负值，且扣 除后的营业收入低于 3 亿元。" ...

Core Viewpoint - Zhejiang Dali Technology Co., Ltd. has signed a procurement framework agreement with a leading new energy company, with a contract value of approximately RMB 88.879359 million, which is expected to positively impact the company's future operating performance [2] Group 1: Contract Details - The contract amount is RMB 88.879359 million (including tax) for the procurement of cold storage thermal imaging instruments [2] - The contract is expected to account for 32.34% of the company's audited revenue for the fiscal year 2024 [2] - Delivery schedules will be executed according to the contract terms or the client's delivery plan [2] Group 2: Client and Market Position - The client has a good credit status and strong contract performance capability, with no related party relationship between the company and the client [2] - The electric power and industrial monitoring sectors are traditional advantageous markets for the company's civilian products [2] Group 3: Strategic Implications - The successful bid for the cold storage thermal imaging project validates the company's entry into the new energy battery industry supply chain [2] - The project reflects the company's recognized expertise in the new energy sector and is expected to positively influence the market expansion of its infrared temperature monitoring system business [2]

Key Points - Roman Co., Ltd. has a relatively small business scale and market share due to the short establishment time of its subsidiary, Wutong High-tech [1] - Filihua expects that the revenue from its quartz electronic cloth business will account for approximately 5% of the company's total revenue by 2025 [1] - Neusoft Carrier's subsidiary plans to invest in the construction of a national new energy storage innovation center in Foshan Nanhai [1] - ST Dali has signed a contract worth 88.879 million yuan [1] - Huaming Equipment anticipates a net profit growth of 15.54% year-on-year in 2025 and plans to distribute 2.1 yuan per 10 shares [1] - Aokema intends to acquire 45% equity in a smart industry company for 253 million yuan [1] - Guangzhou Restaurant has repurchased 1.11% of its shares [1] - Founder Technology plans to reduce its shareholding by no more than 3% [1] - Mind Electronics intends to raise no more than 1 billion yuan through a private placement [1] - ST Huawen has been accepted for reorganization by the court, and its stock will be subject to delisting risk warnings [1]

Group 1 - Hehe Information achieved operating revenue of 1.81 billion yuan in 2025, a year-on-year increase of 25.83%, and net profit of 454 million yuan, a year-on-year increase of 13.39% [1] - Shengyi Technology announced that Guangxin Group and Chen Renxi have completed their share reduction plan, with Guangxin Group reducing its shares by 24.29 million, accounting for 1% of the total share capital [2] - Huaci Co., Ltd. received approval from the China Securities Regulatory Commission for its stock issuance to specific targets [3] Group 2 - New Nuo Wei plans to transfer 30.07% of its shares in Guoxin Huijin to Shiyao Holdings for 230 million yuan, with a valuation increase of 94.85% [4] - Tianli Lithium Energy has completed the scheduled maintenance of its lithium iron phosphate production line and resumed production [5] - Jinchuan Electric reported a net profit of 81.218 million yuan in 2025, a year-on-year decrease of 10.87% [6] Group 3 - Shenzhou Taiyue reported a net profit of 798 million yuan in 2025, a year-on-year decrease of 44.09% [7] - Jingwei Hengrun achieved a net profit of 99.5375 million yuan in 2025, reversing a loss from the previous year [8] - Keheng Technology signed a maximum pledge contract worth 450 million yuan to support its supply chain procurement [9] Group 4 - Zhongchu Media reported a net loss of 20.2858 million yuan in 2025, with operating revenue of 157 million yuan, a year-on-year decrease of 18.99% [10] - Tongde Chemical's subsidiary is involved in a lawsuit with a claim amount of approximately 49.1824 million yuan [12] - Jichuan Pharmaceutical signed an exclusive commercialization rights agreement for a new eczema treatment, with payments not exceeding 190 million yuan [13] Group 5 - Tianli Lithium Energy reported a net loss of 211 million yuan in 2025, with operating revenue of 408 million yuan, a year-on-year decrease of 20.20% [14] - Fortune Trend achieved a net profit of 315 million yuan in 2025, a year-on-year increase of 3.62% [15] - CITIC Securities received approval to publicly issue corporate bonds totaling no more than 80 billion yuan [16] Group 6 - Yongshan Lithium Industry reported a reduction of 23 million shares by Ningbo Jutai, decreasing its total shareholding from 13.24% to 4.52% [17] - Taifu Pump Industry achieved a net profit of 17.5631 million yuan in 2025, a year-on-year increase of 38.78% [18] - Longxun Co., Ltd. reported a net profit of 172 million yuan in 2025, a year-on-year increase of 19.05% [19] Group 7 - Duori Pharmaceutical's acquisition offer period has expired, and the company's stock will resume trading [20] - Tianhao Energy obtained a loan commitment letter for stock repurchase from a financial institution, with a loan amount not exceeding 90 million yuan [21] - Lijun Co., Ltd. reported a net profit of 57.545 million yuan in 2025, a year-on-year decrease of 52.09% [22] Group 8 - Zhongchumai reported a net profit of 212 million yuan in 2025, a year-on-year increase of 45.55% [23] - Kangxino reported a net profit of 27.8727 million yuan in 2025, reversing a loss from the previous year [24] - Baiao Saitu achieved a net profit of 173 million yuan in 2025, a year-on-year increase of 416.37% [25] Group 9 - Guangxun Technology's private placement application was approved by the Shenzhen Stock Exchange [26] - Sandam Membrane reported a net profit of 378 million yuan in 2025, a year-on-year increase of 19.95% [27] - Shangsheng Electronics reported a net profit of 184 million yuan in 2025, a year-on-year decrease of 21.71% [28] Group 10 - Xin'an Century reported a net profit of 79.2904 million yuan in 2025, reversing a loss from the previous year [29] - Zhenlei Technology achieved a net profit of 133 million yuan in 2025, a year-on-year increase of 582.01% [30] - Fuan Pharmaceutical's subsidiary received approval for a new drug application [32] Group 11 - Baotai reported a net loss of 336 million yuan in 2025, with operating revenue of 934 million yuan [33] - Aohua Endoscope reported a net profit of 11.4619 million yuan in 2025, a year-on-year decrease of 45.45% [34] - Maide Medical reported a net profit of 65.2599 million yuan in 2025, reversing a loss from the previous year [35] Group 12 - Chip Original Co. reported a net loss of 528 million yuan in 2025, with operating revenue of 3.152 billion yuan [36] - Zhongwei Semiconductor set a preliminary transfer price of 43.35 yuan per share for its inquiry [37] - Tieke Railway reported a net profit of 171 million yuan in 2025, a year-on-year decrease of 20.09% [38] Group 13 - Changjiang Electric announced a cash dividend distribution plan of 2.1 yuan per 10 shares for the 2025 fiscal year [39] - Kunheng Shunwei reported a net profit of 46.7676 million yuan in 2025, a year-on-year increase of 26.28% [40] - Ailis reported a net profit of 2.181 billion yuan in 2025, a year-on-year increase of 52.55% [41] Group 14 - Aerospace Software reported a net loss of 11.3126 million yuan in 2025, with operating revenue of 1.216 billion yuan [42] - Qizhong Technology reported a net profit of 266 million yuan in 2025, a year-on-year decrease of 15.16% [43] - Guotou Zhonglu plans to acquire 70% of Luochuan Lingxian Company for 74.8745 million yuan [44] Group 15 - Aokema plans to acquire 45% of its subsidiary for 253 million yuan [45] - ST Dali signed a procurement framework agreement worth 88.8794 million yuan with a leading new energy company [46] - Zhifei Biological received clinical trial approval for a new mRNA vaccine [47]

Group 1 - The core point of the article is that *ST Dali (002214.SZ) has signed a procurement framework agreement with a leading new energy company, with a contract value estimated at RMB 88.879359 million, which is categorized as a routine business contract for the company [1] Group 2 - The contract amount is significant, indicating potential growth opportunities for the company in the new energy sector [1] - The agreement reflects the company's ongoing efforts to strengthen its operational capabilities and expand its market presence [1] - This procurement is part of the company's daily operations, suggesting stability in its business activities [1]